Related Experiment Video

Updated: Oct 19, 2026

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease
09:24

Repeated Measurement of Respiratory Muscle Activity and Ventilation in Mouse Models of Neuromuscular Disease

Published on: April 17, 2017

Migrating atelectasis in Werdnig-Hoffmann disease: pulmonary manifestations in two cases of spinal muscular atrophy

E A Leistikow1, N E Jones, K D Josephson

  • 1Neonatal-Perinatal Medicine Division of the Pediatrix Medical Group, Gulf Coast Medical Center, Panama City, Florida 32406-5309, USA. Elizabeth_Leistikow@att.net

Pediatric Pulmonology
|July 28, 1999
PubMed

Insights

Spinal muscular atrophy (SMA), a common neuromuscular disease, can present with early pulmonary issues. Migrating or rotating atelectasis may indicate infantile SMA diagnosis in newborns.

Area of Science:

  • Neurology
  • Pediatrics
  • Pulmonology

Background:

  • Spinal muscular atrophy (SMA), also known as Werdnig-Hoffmann disease, is the second most prevalent neuromuscular disorder.
  • It is an autosomal-recessive condition linked to deletions in the survival motor neuron gene, affecting approximately 1 in 10,000 births.
  • Infantile SMA presents with severe hypotonia, feeding difficulties, respiratory distress, and rapid progression, often leading to early mortality.

Observation:

  • This study identifies migrating or rotating atelectasis as an additional early pulmonary manifestation in infantile SMA.
  • Observed in two patients with infantile spinal muscular atrophy.
  • This specific type of atelectasis may serve as a diagnostic clue.

Findings:

  • Migrating or rotating atelectasis is presented as a novel early pulmonary sign in infantile spinal muscular atrophy.
  • The presence of this condition was noted in two infants diagnosed with SMA.
  • This finding suggests a potential link between this pulmonary issue and the underlying neuromuscular disease.

Implications:

  • Recognizing migrating or rotating atelectasis could lead to earlier diagnosis of spinal muscular atrophy in infants.
  • This may prompt earlier intervention, potentially improving outcomes for affected newborns.
  • Further research into the relationship between SMA and pulmonary manifestations like atelectasis is warranted.

More Related Videos

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury10:49

Intraspinal Cell Transplantation for Targeting Cervical Ventral Horn in Amyotrophic Lateral Sclerosis and Traumatic Spinal Cord Injury

Published on: September 18, 2011

Related Concept Videos

Atelectasis II: Pathophysiology01:10

Atelectasis II: Pathophysiology

Atelectasis develops when alveoli lose their air and collapse inward. Because lung tissue is naturally elastic, these air sacs shrink rather than remaining open. Collapsed alveoli are no longer ventilated, reducing their role in gas exchange. Blood flow may continue in these regions, creating a ventilation–perfusion mismatch. Clinical findings include decreased breath sounds, dullness to percussion, reduced chest expansion, and decreased tactile fremitus as sound transmission through collapsed...
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD: